Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

ShcA signalling is essential for tumour progression in mouse models of human breast cancer.

Ursini-Siegel J, Hardy WR, Zuo D, Lam SH, Sanguin-Gendreau V, Cardiff RD, Pawson T, Muller WJ.

EMBO J. 2008 Mar 19;27(6):910-20. doi: 10.1038/emboj.2008.22. Epub 2008 Feb 14.

PMID:
18273058
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production.

Leung WH, Bolland S.

J Immunol. 2007 Jul 1;179(1):95-102.

PMID:
17579026
[PubMed - indexed for MEDLINE]
Free Article
3.

Trastuzumab: triumphs and tribulations.

Nahta R, Esteva FJ.

Oncogene. 2007 May 28;26(25):3637-43. Review.

PMID:
17530017
[PubMed - indexed for MEDLINE]
4.

Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control.

Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, Pawson T, Muthuswamy SK.

Nat Cell Biol. 2006 Nov;8(11):1235-45. Epub 2006 Oct 22.

PMID:
17060907
[PubMed - indexed for MEDLINE]
5.

Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.

Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, Marshall GM, Gunning PW, Kavallaris M.

J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74.

PMID:
17018783
[PubMed - indexed for MEDLINE]
Free Article
7.

Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression.

Henson ES, Hu X, Gibson SB.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):845-53.

PMID:
16467098
[PubMed - indexed for MEDLINE]
Free Article
8.

A quantitative protein interaction network for the ErbB receptors using protein microarrays.

Jones RB, Gordus A, Krall JA, MacBeath G.

Nature. 2006 Jan 12;439(7073):168-74. Epub 2005 Nov 6.

PMID:
16273093
[PubMed - indexed for MEDLINE]
9.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N.

N Engl J Med. 2005 Oct 20;353(16):1673-84.

PMID:
16236738
[PubMed - indexed for MEDLINE]
Free Article
10.

The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation.

Kim H, Chan R, Dankort DL, Zuo D, Najoukas M, Park M, Muller WJ.

Oncogene. 2005 Nov 17;24(51):7599-607.

PMID:
16170374
[PubMed - indexed for MEDLINE]
11.

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

Pupa SM, Tagliabue E, Ménard S, Anichini A.

J Cell Physiol. 2005 Oct;205(1):10-8. Review.

PMID:
15887236
[PubMed - indexed for MEDLINE]
12.

Memo mediates ErbB2-driven cell motility.

Marone R, Hess D, Dankort D, Muller WJ, Hynes NE, Badache A.

Nat Cell Biol. 2004 Jun;6(6):515-22. Epub 2004 May 23.

PMID:
15156151
[PubMed - indexed for MEDLINE]
13.

Mitogen-activated protein kinases in apoptosis regulation.

Wada T, Penninger JM.

Oncogene. 2004 Apr 12;23(16):2838-49. Review.

PMID:
15077147
[PubMed - indexed for MEDLINE]
14.

The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis.

Saucier C, Khoury H, Lai KM, Peschard P, Dankort D, Naujokas MA, Holash J, Yancopoulos GD, Muller WJ, Pawson T, Park M.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2345-50.

PMID:
14983012
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Mechanisms of Taxol resistance related to microtubules.

Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB.

Oncogene. 2003 Oct 20;22(47):7280-95. Review.

PMID:
14576838
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L, Schmidt M, Mills GB, Mendelsohn J, Fan Z.

Oncogene. 2003 May 22;22(21):3205-12.

PMID:
12761490
[PubMed - indexed for MEDLINE]
17.

The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS.

Cell. 2002 Oct 4;111(1):29-40. Erratum in: Cell. 2002 Nov 27;111(5):757..

PMID:
12372298
[PubMed - indexed for MEDLINE]
18.

The Nck family of adapter proteins: regulators of actin cytoskeleton.

Buday L, Wunderlich L, Tamás P.

Cell Signal. 2002 Sep;14(9):723-31. Review.

PMID:
12034353
[PubMed - indexed for MEDLINE]
19.

Crk family adaptors-signalling complex formation and biological roles.

Feller SM.

Oncogene. 2001 Oct 1;20(44):6348-71. Review.

PMID:
11607838
[PubMed - indexed for MEDLINE]
Free Article
20.

ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS.

Nat Cell Biol. 2001 Sep;3(9):785-92.

PMID:
11533657
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk